DMASP3:

Eshagh Mohammadyari1, Takashi Miwa1, Madhu Golla1

  • 1Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PubMed
概括

向因素D (FD) 和MASP3为补充介导疾病提供了一种新的治疗策略. 在小鼠模型上的研究表明,在人类中抑制这些标的潜力.